Advanced search
Publication Cover
Journal of Psychoactive Drugs Volume 49, 2017 - Issue 2: The Affordable Care Act and Drug Abuse Treatment
Submit an article Journal homepage
441
Views
17
CrossRef citations to date
0
Altmetric
Articles

Commercial Health Plan Coverage of Selected Treatments for Opioid Use Disorders from 2003 to 2014

Sharon ReifSenior Scientist, Institute for Behavioral Health, Heller School for Social Policy and Management, Brandeis University, Waltham, MA, USACorrespondence[email protected]
View further author information
, Ph.D.,
Timothy B. CreedonResearch Associate (TBC), Institute for Behavioral Health, Heller School for Social Policy and Management, Brandeis University, Waltham, MA, USA;Associate Research Scientist, Cambridge Health Alliance, Cambridge, MA, USAView further author information
, M.A.,
Constance M. HorganProfessor and Director, Institute for Behavioral Health, Heller School for Social Policy and Management, Brandeis University, Waltham, MA, USAView further author information
, Sc.D.,
Maureen T. StewartScientist, Institute for Behavioral Health, Heller School for Social Policy and Management, Brandeis University, Waltham, MA, USAView further author information
, Ph.D. &
Deborah W. GarnickProfessor, Institute for Behavioral Health, Heller School for Social Policy and Management, Brandeis University, Waltham, MA, USAView further author information
, Sc.D.
Pages 102-110 | Received 15 Dec 2016, Accepted 14 Feb 2017, Published online: 28 Mar 2017

Citations (17)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (2)

Barbara Andraka-Christou, Olivia Golan, Rachel Totaram, Maggie Ohama, Brendan Saloner, Adam J. Gordon & Bradley D. Stein. (2023) Prior authorization restrictions on medications for opioid use disorder: trends in state laws from 2005 to 2019. Annals of Medicine 55:1, pages 514-520.
Read now
Lucas Kosobuski, Carolyn O’Donnell, Cynthia P Koh-Knox Sharp, Nathaniel Chen & Laura Palombi. (2022) The Role of the Pharmacist in Combating the Opioid Crisis: An Update. Substance Abuse and Rehabilitation 13, pages 127-138.
Read now

Articles from other publishers (15)

Barbara Andraka-ChristouKosali I. SimonW. David BradfordThuy Nguyen. (2023) Buprenorphine Treatment For Opioid Use Disorder: Comparison Of Insurance Restrictions, 2017–21. Health Affairs 42:5, pages 658-664.
Crossref
Alisa B. Busch, Alene Kennedy-Hendricks, Cameron Schilling, Elizabeth A. Stuart, Mara Hollander, Mark K. Meiselbach, Colleen L. Barry, Haiden A. Huskamp & Matthew D. Eisenberg. (2023) Measurement Approaches to Estimating Methadone Continuity in Opioid Use Disorder Care. Medical Care 61:5, pages 314-320.
Crossref
Andrew Terranella, Gery P. GuyJrJr & Christina Mikosz. (2023) Buprenorphine Dispensing Among Youth Aged ≤19 Years in the United States: 2015–2020. Pediatrics 151:2.
Crossref
Natrina L. Johnson, Sugy Choi & Carolina-Nicole Herrera. (2022) Black clients in expansion states who used opioids were more likely to access medication for opioid use disorder after ACA implementation. Journal of Substance Abuse Treatment 133, pages 108533.
Crossref
Noa Krawczyk, Arthur Robin Williams, Brendan Saloner & Magdalena Cerdá. (2021) Who stays in medication treatment for opioid use disorder? A national study of outpatient specialty treatment settings. Journal of Substance Abuse Treatment 126, pages 108329.
Crossref
Kelly E. Anderson, Brendan Saloner, Julia Eckstein, Christine E. Chaisson, Sarah H. Scholle, Lauren Niles, Sydney Dy & G. Caleb Alexander. (2021) Quality of Buprenorphine Care for Insured Adults With Opioid Use Disorder. Medical Care 59:5, pages 393-401.
Crossref
Ramin Mojtabai, Christine Mauro, Melanie M. Wall, Colleen L. Barry & Mark Olfson. (2020) Private health insurance coverage of drug use disorder treatment: 2005–2018. PLOS ONE 15:10, pages e0240298.
Crossref
Alisa B. Busch, Shelly F. Greenfield, Sharon Reif, Sharon-Lise T. Normand & Haiden A. Huskamp. (2020) Outpatient care for opioid use disorder among the commercially insured: Use of medication and psychosocial treatment. Journal of Substance Abuse Treatment 115, pages 108040.
Crossref
Edouard CoupetJrJr, Rachel M. Werner, Daniel Polsky, David Karp & M. Kit Delgado. (2020) Impact of the Young Adult Dependent Coverage Expansion on Opioid Overdoses and Deaths: a Quasi-Experimental Study. Journal of General Internal Medicine 35:6, pages 1783-1788.
Crossref
Hefei WenBenjamin G. DrussBrendan Saloner. (2020) Self-Help Groups And Medication Use In Opioid Addiction Treatment: A National Analysis. Health Affairs 39:5, pages 740-746.
Crossref
Austin S. Kilaru, Aria Xiong, Margaret Lowenstein, Zachary F. Meisel, Jeanmarie Perrone, Utsha Khatri, Nandita Mitra & M. Kit Delgado. (2020) Incidence of Treatment for Opioid Use Disorder Following Nonfatal Overdose in Commercially Insured Patients. JAMA Network Open 3:5, pages e205852.
Crossref
Daniel PolskySamantha ArsenaultFrancisca Azocar. (2020) Private Coverage of Methadone in Outpatient Treatment Programs. Psychiatric Services 71:3, pages 303-306.
Crossref
Sharon Reif, Mary F. Brolin, Maureen T. Stewart, Thomas J. Fuchs, Elizabeth Speaker & Shayna B. Mazel. (2020) The Washington State Hub and Spoke Model to increase access to medication treatment for opioid use disorders. Journal of Substance Abuse Treatment 108, pages 33-39.
Crossref
Amanda J. Abraham, Christina M. Andrews, Samantha J. Harris & Peter D. Friedmann. (2020) Availability of Medications for the Treatment of Alcohol and Opioid Use Disorder in the USA. Neurotherapeutics 17:1, pages 55-69.
Crossref
Norah Mulvaney-DayBrent J. GibbonsShums AlikhanMustafa Karakus. (2019) Mental Health Parity and Addiction Equity Act and the Use of Outpatient Behavioral Health Services in the United States, 2005–2016. American Journal of Public Health 109:S3, pages S190-S196.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.